TELLYES SCIENTIFIC
Innovative medical education solutions featuring advanced VR technology and high-end simulation products
About TELLYES SCIENTIFIC
Tellyes Scientific Inc. is a high-tech enterprise specializing in the research, development, production, and sales of modern medical education products. The company, which went public on the NEEQ in July 2015 under the stock symbol 833047, focuses on technological innovation and the development of products with independent intellectual property rights. Tellyes is a leader in virtual reality technology and services for medical education and is recognized as the enterprise Technology Center of Tianjin and the Engineering Center of Traditional Chinese Medicine and Medical Virtual Technology.
Tellyes serves educational institutions, medical schools, and healthcare professionals by providing highly realistic medical simulation products. These products include CPR defibrillation manikins with highly simulated anatomical structures and LungsReady breathing simulators capable of simulating respiratory diseases across different ages and genders. The company operates in the medical education market, offering solutions that enhance the training and preparedness of healthcare providers.
The business model of Tellyes revolves around the sale of its advanced medical simulation products and services. Revenue is generated through direct sales to educational institutions and healthcare organizations, as well as through partnerships and collaborations with other entities in the medical education sector.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2015
News
Open roles
TELLYES SCIENTIFIC in the Nankai District ecosystem
The TELLYES SCIENTIFIC office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- SCShanghai Capital
Series A3 investors entered at this stage
- CBCBGF
NewMargin Ventures- SCShanshan Venture Capital
Series B and later9 investors entered at this stage
Tebon Securities Co
CICC
GF Securities- TSTianfeng Securities
- CSCapital Securities
Highlight Capital
Haitong International Securities Group- FMFortune Link Fund Management
BOCI
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about TELLYES SCIENTIFIC on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TELLYES SCIENTIFIC on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.